Nanobiotix S.A.
NBTX | NASDAQ
$35.03
+$0.53 (+1.54%)
Sep 22, 2026, 1:40 PM ET · Market open
TTM Period Ending | Q4 2025 Dec 30, 2025 | Q2 2025 Jun 29, 2025 | Q4 2024 Dec 30, 2024 | Q2 2024 Jun 29, 2024 | Q4 2023 Dec 30, 2023 | Q2 2023 Jun 29, 2023 | Q4 2022 Dec 30, 2022 | Q2 2022 Jun 29, 2022 | Q4 2021 Dec 30, 2021 | Q2 2021 Jun 29, 2021 | Q4 2020 Dec 30, 2020 | Q2 2020 Jun 29, 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 29.64M | 5.74M | -11.61M | 42.2M | 36.21M | 5.02M | 2.39M | 1.33M | 674K | 23K | 50K | 68K |
Cost of Revenue | n/a | n/a | n/a | n/a | n/a | 754K | 1.5M | 1.51M | 109.5K | -1.08M | -1.11M | -1.02M |
Gross Profit | 29.64M | 5.74M | -11.61M | 42.2M | 36.21M | 4.26M | 888K | -176.5K | 564.5K | 1.1M | 1.16M | 1.08M |
Operating Income | -10.82M | -43.93M | -68.39M | -25.06M | -26.78M | -49.62M | -50.49M | -50.38M | -49.8M | -44.77M | -39M | -46.79M |
Interest Income | 985K | 2.63M | 2.63M | n/a | n/a | 250K | 1.61M | 2.58M | 2.78M | 2.58M | 1.03M | 458.5K |
Pretax Income | -23.96M | -51.68M | -68.03M | -33.21M | -39.58M | -61.81M | -61.12M | -45.25M | -49.49M | -45.69M | -35.51M | -49.12M |
Net Income | -23.96M | -51.64M | -68.13M | -33.47M | -39.7M | -58.78M | -57.04M | -42.94M | -47M | -43.43M | -33.59M | -47.57M |
Selling & General & Admin | 20.22M | 20.99M | 20.53M | 22.02M | 22.05M | 18.85M | 17.48M | 18.51M | 19.02M | 17.73M | 14.22M | 16.27M |
Research & Development | 23.12M | 33.08M | 40.54M | 42.58M | 38.4M | 33.34M | 31.47M | 30.29M | 29.23M | 25.43M | 23.04M | 28.66M |
Other Expenses | -2.88M | -4.4M | -4.29M | 2.67M | 2.54M | -31K | 43K | 68K | n/a | -12K | 40K | 104K |
Operating Expenses | 40.46M | 49.67M | 56.78M | 67.27M | 62.99M | 52.16M | 48.99M | 48.87M | 48.25M | 43.14M | 37.3M | 45.03M |
Interest Expense | 10.4M | 11.73M | 8.09M | 3.4M | 6.77M | 6.48M | 3.11M | n/a | n/a | n/a | 1.19M | 1.19M |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -14.5K | -14.5K |
Cost & Expenses | 40.46M | 49.67M | 56.78M | 67.27M | 62.99M | 52.91M | 50.49M | 50.38M | 49.81M | 44.79M | 39.05M | 46.86M |
Income Tax Expense | 3K | -37K | 101K | 261K | 120K | -3.03M | -4.08M | -2.31M | -2.49M | -2.26M | -1.92M | -1.55M |
Shares Outstanding (Basic) | 47.82M | 47.42M | 47.27M | 47.12M | 37.99M | 35.04M | 34.85M | 34.84M | 34.81M | 34.62M | 27.85M | 22.61M |
Shares Outstanding (Diluted) | 47.82M | 47.42M | 47.27M | 47.12M | 38.82M | 35.04M | 34.85M | 34.84M | 34.81M | 34.62M | 27.85M | 22.61M |
EPS (Basic) | -0.50 | -1.09 | -1.44 | -0.76 | -1.10 | -1.68 | -1.64 | -1.24 | -1.36 | -1.35 | -1.38 | -2.12 |
EPS (Diluted) | -0.50 | -1.09 | -1.44 | -0.77 | -1.11 | -1.68 | -1.64 | -1.24 | -1.36 | -1.35 | -1.38 | -2.12 |
EBITDA | -12.07M | -33.99M | -58.32M | -21.83M | -23.22M | -34.9M | -21.97M | -22.27M | -21.93M | -19.52M | -16.88M | -20.98M |
EBIT | -13.56M | -35.6M | -59.95M | -22.39M | -24.24M | -35.78M | -22.86M | -23.86M | -23.58M | -21.3M | -18.31M | -22.35M |
Depreciation & Amortization | 1.5M | 1.61M | 1.62M | 561K | 1.02M | 1.5M | 1.5M | 1.51M | 1.56M | 1.65M | 1.76M | 1.83M |
Add to Watchlist
Select watchlists to add or remove NBTX